I

Inizio

Guides clinical development and commercialization

Research Manager

Full-TimeUpdated on 10/15/2026
No salary listed
Mid
Singapore
HybridTwo days per week in the office.
Data & AnalyticsData Analysis

About the job

Requirements
  • At least 4 years of experience in market research with healthcare experience.
  • An appreciation of marketing and client-side issues.
  • Ability to work independently.
  • Ability to manage multiple tasks under pressure and meet tight deadlines.
Responsibilities
  • Ensure the smooth running and high-quality delivery of quantitative brand equity tracking programs, producing actionable insights.
  • Work on broader custom quantitative and qualitative research projects.
  • Write questionnaires, test survey links, and ensure data integrity throughout the research process, with input from the manager.
  • Analyze data and report findings, identifying key trends and insights.
  • Interrogate findings and help craft compelling presentations alongside senior team members.
  • Focus on specific therapeutic areas and collaborate directly with clients to support brand planning and strategic development.
  • Support the Director in running workshops and help client teams translate research insights into strategic brand development and decision-making.
  • Mentor and manage junior team members, ensuring best practices and knowledge sharing within the team.
Desired Qualifications
  • Proactive, dedicated, and enthusiastic approach.
  • High level of accuracy and attention to detail, with strengths in organization, prioritization, and problem-solving.
  • Ability to work collaboratively with colleagues.
  • Ability to communicate ideas and issues in an effective, straightforward manner.
  • Motivation to develop new skills and progress in a career.

About the company

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Inizio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Inizio won two PM360 2026 Innovation Awards for AI and technology.
  • Connected Insights launched July 28, 2026, expanding global medical-information workflows and APAC reach.
  • Intelligent Congress launched May 12, 2026, tying congress spend to measurable outcomes.

What critics are saying

  • S&P cut Inizio to B- in May 2025, citing 8.5x-9x leverage in 2026.
  • The 2025 annual report booked $16.7 million restructuring charges, signaling continuing workforce cuts.
  • Debt service can crowd out investment and force sponsor distributions before a refinancing crunch.

What makes Inizio unique

  • Inizio Ignite unites Research Partnership, Putnam, Vynamic, and STEM into one advisory platform.
  • Inizio Engage combines hub services, pharmacy, analytics, and patient access across 20 countries.
  • Inizio spans five businesses, giving clients strategy-through-execution coverage across the product lifecycle.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

8%
PR Newswire
Sep 9th, 2026
Inizio appoints Oisín Ó Gógáin as chief people officer to lead growth strategy

Inizio, a global commercialisation partner for health and life sciences companies, has appointed Oisín Ó Gógáin as chief people officer. The Dublin and London-based company employs 10,900 people across five business units. Ó Gógáin joins from Aon, where he served as chief people officer for the UK, Ireland, and South Africa, supporting approximately 10,000 colleagues. During his 14 years at Aon, he held senior HR roles across Europe and the US. Based at Inizio's Dublin headquarters, Ó Gógáin brings experience in organisational change, acquisitions and integrations, and building talent pipelines. His appointment comes as Inizio scales its people strategy alongside company growth. Chief executive officer Ryan Quigley said Ó Gógáin's experience building inclusive, high-performing cultures makes him suited to support the company's next phase.

PR Newswire
Jul 28th, 2026
Inizio launches AI-enabled Connected Insights to transform medical information into strategic intelligence

Inizio has expanded its Global Medical Information capabilities through Inizio Engage, launching Connected Insights to help pharmaceutical and biotechnology companies transform medical information into strategic intelligence. The service combines expanded Asia-Pacific expertise, enhanced global infrastructure, and AI-enabled innovation. The company supports more than one million medical information interactions annually across 500+ products in 55+ global programmes, delivering services in over 20 languages. AI-powered features have increased training simulations tenfold and improved training success by 50%. The expansion includes continued growth across the APAC region, expanded global infrastructure, and AI-enabled innovations throughout the medical information workflow, including AI-powered training personas, speech analytics, and virtual agents. The investment reinforces Inizio's commitment to connecting scientific expertise with technology and data-driven insight across the product lifecycle.

PR Newswire
May 12th, 2026
Inizio launches Intelligent Congress solution to measure medical event impact

Inizio, a global commercialisation partner to health and life sciences companies, has launched Intelligent Congress, an end-to-end solution designed to maximise the value of medical congress investments and deliver measurable business impact. The platform addresses fragmented planning and unclear objectives that often dilute congress opportunities. It integrates strategy, experience design, delivery and measurement across the full congress lifecycle, enabling clients to focus on meaningful shifts in healthcare professional engagement and behaviour rather than isolated metrics. Intelligent Congress uses a four-step framework spanning the entire congress calendar, capturing real-time insights and evaluating impact against key datasets. Inizio has supported over 80 clients across 27 countries, facilitating more than 1,000 healthcare professional engagements and managing over 25,500 attendees.

PR Newswire
Apr 23rd, 2026
Inizio launches integrated hub services combining analytics, pharmacy and specialist support to improve patient access

Inizio has launched its fully integrated Hub Services through its Inizio Engage business unit, targeting improved patient access, reimbursement and adherence for life sciences companies. The solution combines advanced analytics, pharmacy capabilities and specialised expertise to streamline the patient journey. The offering includes non-dispensing pharmacy services for benefit verification and fulfilment coordination, comprehensive access and reimbursement support, field reimbursement services and non-commercial dispensing pharmacy. Advanced analytics predict potential delays before they occur. Inizio Engage, which employs over 6,000 experts across 20 countries and delivers over 5 million engagements annually, will showcase the service at the Asembia Summit in Las Vegas from 27–30 April 2026. The company has made significant investments in leadership across patient access, pharmacy, reimbursement and analytics to support the service.

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization